• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,488.96 1,073.61
( 1.42%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
65,182.04 1,842.97
(2.91%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540694
INE236W01016
49.9768362
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
37.69
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales18.3025.9724.53
Other Operating Income0.000.000.00
Other Income 0.160.210.17
Total Income18.4626.1824.71
Total Expenditure 20.3823.7522.68
PBIDT-1.922.422.03
Interest 1.611.591.61
PBDT-3.520.840.42
Depreciation1.451.451.45
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.740.18-0.24
Reported Profit After Tax-4.24-0.80-0.79
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-4.24-0.80-0.79
EPS (Unit Curr.)-3.23-0.60-0.59
EPS (Adj) (Unit Curr.)-3.23-0.60-0.59
Calculated EPS (Unit Curr.)-3.25-0.61-0.60
Calculated EPS (Adj) (Unit Curr.)-3.25-0.61-0.60
Calculated EPS (Ann.) (Unit Curr.)-12.99-2.45-2.41
Calculated EPS (Adj) (Ann.) (Unit Curr.)-12.99-2.45-2.41
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity13.0613.0613.06
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-10.499.328.28
PBDTM(%)-19.233.231.71
PATM(%)-23.17-3.08-3.22